These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 1416892)

  • 1. Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients.
    Naumovski L; Quinn JP; Miyashiro D; Patel M; Bush K; Singer SB; Graves D; Palzkill T; Arvin AM
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1991-6. PubMed ID: 1416892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel plasmid-mediated beta-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae.
    Quinn JP; Miyashiro D; Sahm D; Flamm R; Bush K
    Antimicrob Agents Chemother; 1989 Sep; 33(9):1451-6. PubMed ID: 2684007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli isolates producing TEM-10 and TEM-43 beta-lactamases from St. Louis, Missouri.
    Yang Y; Bhachech N; Bradford PA; Jett BD; Sahm DF; Bush K
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1671-6. PubMed ID: 9661002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiply resistant Klebsiella pneumoniae strains from two Chicago hospitals: identification of the extended-spectrum TEM-12 and TEM-10 ceftazidime-hydrolyzing beta-lactamases in a single isolate.
    Bradford PA; Cherubin CE; Idemyor V; Rasmussen BA; Bush K
    Antimicrob Agents Chemother; 1994 Apr; 38(4):761-6. PubMed ID: 8031043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel transferable extended-spectrum beta-lactamase (SHV-6) from Klebsiella pneumoniae conferring selective resistance to ceftazidime.
    Arlet G; Rouveau M; Bengoufa D; Nicolas MH; Philippon A
    FEMS Microbiol Lett; 1991 Jun; 65(1):57-62. PubMed ID: 1874404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae.
    Papanicolaou GA; Medeiros AA; Jacoby GA
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2200-9. PubMed ID: 1963529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of a transferable SHV-5 type beta-lactamase in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Greece.
    Vatopoulos AC; Philippon A; Tzouvelekis LS; Komninou Z; Legakis NJ
    J Antimicrob Chemother; 1990 Nov; 26(5):635-48. PubMed ID: 2079446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of TEM-26 beta-lactamase responsible for a major outbreak of ceftazidime-resistant Klebsiella pneumoniae.
    Urban C; Meyer KS; Mariano N; Rahal JJ; Flamm R; Rasmussen BA; Bush K
    Antimicrob Agents Chemother; 1994 Feb; 38(2):392-5. PubMed ID: 8192474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetically diverse ceftazidime-resistant isolates from a single center: biochemical and genetic characterization of TEM-10 beta-lactamases encoded by different nucleotide sequences.
    Rasmussen BA; Bradford PA; Quinn JP; Wiener J; Weinstein RA; Bush K
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1989-92. PubMed ID: 8239618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can results obtained with commercially available MicroScan microdilution panels serve as an indicator of beta-lactamase production among escherichia coli and Klebsiella isolates with hidden resistance to expanded-spectrum cephalosporins and aztreonam?
    Moland ES; Sanders CC; Thomson KS
    J Clin Microbiol; 1998 Sep; 36(9):2575-9. PubMed ID: 9705395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmid-mediated beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli resistant to ceftazidime.
    Vuye A; Verschraegen G; Claeys G
    Antimicrob Agents Chemother; 1989 May; 33(5):757-61. PubMed ID: 2665644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular genetics of resistance to both ceftazidime and beta-lactam-beta-lactamase inhibitor combinations in Klebsiella pneumoniae and in vivo response to beta-lactam therapy.
    Rice LB; Carias LL; Bonomo RA; Shlaes DM
    J Infect Dis; 1996 Jan; 173(1):151-8. PubMed ID: 8537652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel, plasmid-encoded, TEM-derived extended-spectrum beta-lactamase in Klebsiella pneumoniae conferring higher resistance to aztreonam than to extended-spectrum cephalosporins.
    Arlet G; Rouveau M; Fournier G; Lagrange PH; Philippon A
    Antimicrob Agents Chemother; 1993 Sep; 37(9):2020-3. PubMed ID: 8239625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z; Kayacan C; Oncul O
    Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes.
    Wiener J; Quinn JP; Bradford PA; Goering RV; Nathan C; Bush K; Weinstein RA
    JAMA; 1999 Feb; 281(6):517-23. PubMed ID: 10022107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of extended-spectrum beta-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli.
    Jacoby GA; Han P
    J Clin Microbiol; 1996 Apr; 34(4):908-11. PubMed ID: 8815106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel plasmid-mediated beta-lactamase in clinical isolates of Klebsiella pneumoniae more resistant to ceftazidime than to other broad-spectrum cephalosporins.
    Petit A; Sirot DL; Chanal CM; Sirot JL; Labia R; Gerbaud G; Cluzel RA
    Antimicrob Agents Chemother; 1988 May; 32(5):626-30. PubMed ID: 3293523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence of Ceftazidime-Avibactam Resistance Due to Plasmid-Borne
    Shields RK; Chen L; Cheng S; Chavda KD; Press EG; Snyder A; Pandey R; Doi Y; Kreiswirth BN; Nguyen MH; Clancy CJ
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-level expression of chromosomally encoded SHV-1 beta-lactamase and an outer membrane protein change confer resistance to ceftazidime and piperacillin-tazobactam in a clinical isolate of Klebsiella pneumoniae.
    Rice LB; Carias LL; Hujer AM; Bonafede M; Hutton R; Hoyen C; Bonomo RA
    Antimicrob Agents Chemother; 2000 Feb; 44(2):362-7. PubMed ID: 10639363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular epidemiology of ceftazidime resistant Enterobacteriaceae from patients on a paediatric oncology ward.
    Hibbert-Rogers LC; Heritage J; Gascoyne-Binzi DM; Hawkey PM; Todd N; Lewis IJ; Bailey C
    J Antimicrob Chemother; 1995 Jul; 36(1):65-82. PubMed ID: 8537285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.